Rebecca Thomas, MSOTR/L | |
859 Landy Hill Rd, Bedford, KY 40006-8642 | |
(502) 663-3588 | |
Not Available |
Full Name | Rebecca Thomas |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 859 Landy Hill Rd, Bedford, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003148834 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | T4265 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Thomas, MSOTR/L 859 Landy Hill Rd, Bedford, KY 40006-8642 Ph: (502) 663-3588 | Rebecca Thomas, MSOTR/L 859 Landy Hill Rd, Bedford, KY 40006-8642 Ph: (502) 663-3588 |
News Archive
High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.
A team of international scientists has recently developed virus-like particles (VLPs) by coating liposomes with the synthetic spike glycoprotein of SARS-CoV-2.
A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.
However, it cannot be confirmed for certain that the strain has been eliminated, raising the question of how long a strain must go undetected before being considered, in all probability, extinct.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
› Verified 6 days ago